4//SEC Filing
Morris Charles Q 4
Accession 0001415889-25-004525
CIK 0001840748other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:15 PM ET
Size
5.6 KB
Accession
0001415889-25-004525
Insider Transaction Report
Form 4
Morris Charles Q
Chief Medical Officer
Transactions
- Award
Share Options (Right to Buy)
2025-02-13+130,850→ 130,850 totalExercise: $0.93Exp: 2035-03-12→ Common Shares (130,850 underlying)
Footnotes (1)
- [F1]The shares underlying the option vest in 48 equal monthly installments beginning on March 13, 2025, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on each such vesting date.
Documents
Issuer
LAVA Therapeutics NV
CIK 0001840748
Entity typeother
Related Parties
1- filerCIK 0001489966
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:15 PM ET
- Size
- 5.6 KB